In a challenging economic environment coming out of the COVID-19 pandemic, US health systems are accelerating diversification strategies to participate in new, high-growth healthcare segments and to support core hospital operations. They are seeking to simultaneously diversify revenue sources outside of core hospital operations and build (or acquire) capabilities that can also benefit the core—for example, by improving patient access, quality of care, experience, and affordability.
McKinsey & Company surveyed health system executives to learn more about their diversification strategies. More than 70 percent of survey respondents said they intend to invest more in diversification over the next three years. Read more.
